Article Information
History
- May 14, 2022.
Article Versions
- You are currently viewing Version 1 of this article (May 14, 2022 - 14:28).
- Version 2 (August 9, 2022 - 23:56).
- Version 3 (September 25, 2022 - 01:39).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Celia Sze Ling Mak1,
- Ming Zhu1,
- Xin Liang1,
- Feng Wang2,
- Anh G Hoang1,
- Xinzhi Song2,
- Peter Shepherd1,
- Derek Liang1,
- Jiwon Park1,
- Miao Zhang3,
- Eric Metzger4,
- Roland Schüle4,
- Abhinav K. Jain5,
- Min Gyu Lee6,
- Paul Corn1,
- Christopher J. Logothetis1,
- Ana Aparicio1,
- Nora Navone1,
- Patricia Troncoso3,
- Jianhua Zhang2,
- Sue-Hwa Lin1,7 and
- Guocan Wang1,*
- 1Department of Genitourinary Medical Oncology and the David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 2Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 3Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 4Klinik für Urologie und Zentrale Klinische Forschung, Klinikum der Albert-Ludwigs-Universität Freiburg, Germany
- 5Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 6Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- 7Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- ↵*Correspondence: Guocan Wang (gwang6{at}mdanderson.org)